Suppression of tumorigenicity in neuroblastoma cells by upregulation of human vasoactive intestinal peptide receptor type 1

@article{Balster2002SuppressionOT,
  title={Suppression of tumorigenicity in neuroblastoma cells by upregulation of human vasoactive intestinal peptide receptor type 1},
  author={Douglas A. Balster and M. Sue O'dorisio and A. H. R. Albers and Sang Kyu Park and Stephen J. Qualman},
  journal={Regulatory Peptides},
  year={2002},
  volume={109},
  pages={155-165}
}
We hypothesize that vasoactive intestinal peptide (VIP) promotes neural crest differentiation through VIP receptor type I (VPAC1). In order to test this hypothesis, SKNSH neuroblastoma cells were stably transfected with VPAC1 and receptor expression was verified by real-time RT-PCR. Overexpression of VPAC1 in SKNSH cells resulted in upregulation of endogenous retinoic acid receptor expression for both RARalpha and RXRalpha with no change in expression of RARbeta. Transfected cells demonstrated… CONTINUE READING
BETA